The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Ishares Msci Korea

NYSE: EWY
Last

(U.S.) $47.99

Today's change-0.15 -0.31%
Updated August 28 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Ishares Msci Korea

NYSE: EWY
Last

(U.S.) $47.99

Today's change-0.15 -0.31%
Updated August 28 4:00 PM -4GMT. Delayed by at least 15 minutes.

Ishares Msci Korea down (U.S.)$0.15

Ishares Msci Korea closed lower Friday, dropping (U.S.)$0.15 or 0.31% to (U.S.)$47.99. Over the last five days, shares have gained 5.08%, but are down 13.20% for the last year to date. Shares have underperformed the S&P 500 by 27.61% during the last year.

Key company metrics

  • Open(U.S.) $47.99
  • Previous close(U.S.) $48.14
  • High(U.S.) $48.13
  • Low(U.S.) $47.76
  • Bid / Ask-- / --
  • YTD % change-13.20%
  • Volume3,472,443
  • Average volume (10-day)5,097,394
  • Average volume (1-month)3,512,706
  • Average volume (3-month)2,756,288
  • 52-week range(U.S.) $42.94 to (U.S.) $66.68
  • Beta1.29
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.56
  • Dividend yield3.25%
  • Trailing EPS(U.S.) -$5.43
Updated August 28 4:00 PM -4GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-651.65%

Ishares Msci Korea has a net profit margin of -651.65%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.71%Sector:FinancialsIndustry:Investment Trusts
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q4/2014Q2/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedFeb 28, 201502/28/2015Aug 31, 201408/31/2014Feb 28, 201402/28/2014Aug 31, 201308/31/2013
Revenue494396
Total other revenue--------
Total revenue494396
Gross profit35-926-4
Total cost of revenue13141310
Total operating expense13141310
Selling / general / administrative--------
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income35-926-4
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-683338263-252
Income after tax-683338263-252
Income tax, total--000
Net income-683338263-252
Total adjustments to net income--------
Net income before extra. items-683338263-252
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-683338263-252
Inc. avail. to common incl. extra. items-683338263-252
Diluted net income-683338263-252
Dilution adjustment--0----
Diluted weighted average shares71806863
Diluted EPS excluding extraordinary itemsvalue per share-9.674.233.90-4.02
Dividends per sharevalue per share0.660.000.900.00
Diluted normalized EPSvalue per share-9.674.233.90-4.02